Irritable bowel syndrome (IBS) is one of the most common gastrointestinal conditions you can get. It’s defined as abdominal pain or discomfort with, ahem, “altered” bowel habits over a period of time.

A low-FODMAP diet is recommended for many people with IBS-C to help prevent flare-ups. Increasing soluble fiber may ease symptoms by making stool softer and easier to pass. Over-the-counter laxatives ...

Amitriptyline can improve symptoms of irritable bowel syndrome in patients seen in GP surgeries, new research has found. The cheap and widely available prescription drug, which is commonly used at low ...

From abdominal pain and bloating to urgent bathroom trips and constipation, irritable bowel syndrome (IBS) can be a disruptive condition to live with. Fortunately, there are treatments available that ...

Irritable bowel syndrome isn’t caused by an infection and cannot be passed on to other people. Irritable bowel syndrome (IBS) isn’t really a singular condition with an exact cause. Instead, it’s a ...

Irritable bowel syndrome (IBS) is a chronic condition that can cause a number of unpleasant digestive symptoms, most notably constipation or diarrhea with abdominal pain. "Gas, cramping and food ...

Yes, irritable bowel syndrome (IBS) is considered a chronic illness. This means that you may need to maintain some lifestyle and dietary habits throughout your lifetime to help manage your symptoms.

Ginger tea can be helpful in treating certain symptoms of irritable bowel syndrome like bloating, cramping, and nausea.

Ovarian cancer and irritable bowel syndrome (IBS) can present with similar symptoms, making it challenging to distinguish between them. Both conditions may cause abdominal discomfort, bloating, and ...

The symptoms of irritable bowel syndrome (IBS) are similar in males and females, but some differences exist. For example, males are more likely than females to report diarrhea, whereas females are ...

Titrated low-dose amitriptyline significantly improved irritable bowel syndrome (IBS) symptoms when used as a second-line treatment in the primary care setting, the randomized ATLANTIS trial showed.